In collaboration with SIDP, the MAD-ID Annual Antimicrobial Stewardship Meeting is offering 4.75 contact hours toward recertification for Board Certified Infectious Diseases Pharmacists (BCIDP). This activity will remain in your My Courses tab after purchase. Pre-registration for BCIDP credit is recommended, but may be completed after attending MAD-ID.
Sessions for BCIDP credit are:
- Keynote: Antimicrobial Stewardship for the Patients We Serve (presented by Matthew B. Goetz, MD) - 5/19/22
- What’s New with COVID?
- Antimicrobial Stewardship Challenges and Response in the COVID-19 Pandemic (presented by Payal K. Patel, MD, MPH) - 5/19/22
- Implementing Diagnostic Stewardship in 2022
- These are Exciting Times: Implementing Diagnostic Stewardship into Traditional Antimicrobial Stewardship Programs (presented by Kimberly C. Claeys, PharmD) - 5/20/22
- Rapid Diagnostics: The Clinical Microbiologist Perspective (presented by Kaede Ota Sullivan, MD, MSc, FRCPC, FAAP, D(ABMM)) - 5/20/22
- Gram Negative Pathogens
- Update on Epidemiology and Patient Outcomes (presented by David van Duin, MD, PhD, FIDSA, FAST) - 5/20/22
- Coming Attractions: Innovations in HIV and Fungal Therapy
- New Developments in HIV, Long-Acting Therapy (presented by Meshell Maxam, PharmD, BCIDP) - 5/21/22
Participants must attend all BCIDP sessions and complete an online post-test and evaluation to receive BCIDP recertification credit hours.
You must register for and attend MAD-ID to be eligible for BCIDP recertification credit. Register for MAD-ID here: https://mad-id.org/2022-annual-meeting/
Learning Objectives & Faculty
The target audience for this activity includes board-certified infectious diseases pharmacists (BCIDPs) seeking to update their knowledge and skills related to contemporary infectious diseases literature review.
Please refer to the MAD-ID Annual Meeting material for specific session and faculty information.
CE Accreditation- BCIDP
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 5/18/2022 for this activity and is available for one year from this date.
Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), American College of Clinical Pharmacy (ACCP) and/or the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosure will be announced through MAD-ID.
This activity is provided by ProCE and SIDP.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Verify Attendance (AMS Challenges and Response in the COVID-19 Pandemic, May 19)
|Date||5/19/2022 1:30:00 PM|